1121 - 1130 of 8587 Results
Title
Year
-
RESTRICTEDTitle: Proteostasis control by the unfolded protein responseJournal Name: Nature Cell BiologyPublisher: Springer Science and Business Media LLCVol: 17Issue #: 7Start Page: 829End Page: 838Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/ncb3184Best OA location URL: https://europepmc.org/articles/pmc5546321?pdf=renderCitation Count: 590
-
RESTRICTEDTitle: The best medicine? The influence of physical activity and inactivity on Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 31Issue #: 10Start Page: 1444End Page: 1454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.26728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9491025Citation Count: 97
-
RESTRICTEDTitle: Prospects of Statins in Parkinson DiseaseJournal Name: The NeuroscientistPublisher: SAGE PublicationsVol: 17Issue #: 3Start Page: 244End Page: 255Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/1073858410385006Best OA location URL: https://europepmc.org/articles/pmc3132406?pdf=renderCitation Count: 86
-
RESTRICTEDTitle: α-Synuclein and Mitochondria: Partners in Crime?Journal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 391End Page: 399Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0182-9Best OA location URL: https://europepmc.org/articles/pmc3701775?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: Intrabodies as Neuroprotective TherapeuticsJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 3Start Page: 447End Page: 458Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0193-6Best OA location URL: https://europepmc.org/articles/pmc3701772?pdf=renderCitation Count: 32
-
RESTRICTEDTitle: Multiplexed Profiling of Extracellular Vesicles for Biomarker DevelopmentJournal Name: Nano-Micro LettersPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40820-021-00753-wBest OA location URL: https://link.springer.com/content/pdf/10.1007/s40820-021-00753-w.pdfCitation Count: 42
-
RESTRICTEDTitle: Epigenetic Landscape of Parkinson’s Disease: Emerging Role in Disease Mechanisms and Therapeutic ModalitiesJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 10Issue #: 4Start Page: 698End Page: 708Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-013-0211-8Best OA location URL: https://europepmc.org/articles/pmc3805874?pdf=renderCitation Count: 73
-
RESTRICTEDTitle: Cell Therapeutics in Parkinson's DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 8Issue #: 4Start Page: 539End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1007/s13311-011-0069-6Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-011-0069-6.pdfCitation Count: 78
-
RESTRICTEDTitle: Urate as a Marker of Risk and Progression of Neurodegenerative DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 148End Page: 153Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-016-0497-4Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-016-0497-4.pdfCitation Count: 74
-
RESTRICTEDTitle: The Nuclear Envelope: An Intriguing Focal Point for Neurogenetic DiseaseJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 11Issue #: 4Start Page: 764End Page: 772Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s13311-014-0296-8Best OA location URL: https://europepmc.org/articles/pmc4391386?pdf=renderCitation Count: 17